From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease (2017)
- Authors:
- USP affiliated authors: HOJO, ELZA TIEMI SAKAMOTO - FFCLRP ; TAKAHASHI, CATARINA SATIE - FFCLRP ; CARVALHO, IVONE - FCFRP
- Unidades: FFCLRP; FCFRP
- DOI: 10.1016/j.ejmech.2017.08.051
- Subjects: DOENÇA DE ALZHEIMER; INIBIDORES DE ENZIMAS; PROLIFERAÇÃO CELULAR
- Keywords: Acetylcholinesterase inhibitors; Allosteric modulators; Alzheimer's disease
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Medicinal Chemistry
- ISSN: 0223-5234
- Volume/Número/Paginação/Ano: v. 139, p. 773-791, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: cc-by-nc-nd
-
ABNT
CHIERRITO, Talita P. C. et al. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease. European Journal of Medicinal Chemistry, v. 139, p. 773-791, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2017.08.051. Acesso em: 27 dez. 2025. -
APA
Chierrito, T. P. C., Mantoani, S. P., Roca, C., Requena, C., Perez, V. S., Castillo, W. O., et al. (2017). From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease. European Journal of Medicinal Chemistry, 139, 773-791. doi:10.1016/j.ejmech.2017.08.051 -
NLM
Chierrito TPC, Mantoani SP, Roca C, Requena C, Perez VS, Castillo WO, Moreira NCS, Pérez C, Sakamoto-Hojo ET, Takahashi CS, Barbero JJ, Cañada FJ, Campillo NE, Martinez A, Carvalho I. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease [Internet]. European Journal of Medicinal Chemistry. 2017 ; 139 773-791.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.ejmech.2017.08.051 -
Vancouver
Chierrito TPC, Mantoani SP, Roca C, Requena C, Perez VS, Castillo WO, Moreira NCS, Pérez C, Sakamoto-Hojo ET, Takahashi CS, Barbero JJ, Cañada FJ, Campillo NE, Martinez A, Carvalho I. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease [Internet]. European Journal of Medicinal Chemistry. 2017 ; 139 773-791.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.ejmech.2017.08.051 - Potentiation clastogenic action ellipticine by dna repair inhibitors caffeine and ara-c
- Potentiation clastogenic effect of elliptirine on different phases of the cell cycle of cultured human lymphocytes and synergistic action with inhibitors of dna repair at g2
- Influence of novobiocin on the clastogenic activity of ellipticine in human lymphocytes in culture
- Acao da novobiocina in vitro sobre as aberracoes cromossomicas radio-induzidas
- Potentiation of the clastogenic action of ellipticine by the dna repair inhibitors caffeine and ara-c
- Inducao de aberracoes cromossomicas em linfocitos humanos irradiados (co-60) e pos-tratados com novobiocina na fase 'G IND.0' do ciclo celular
- Evaluation of the genotoxicity of carbofuran in human peripheral blood lymphocytes
- Reducao nos danos cromossomicos pela 5-aza-cifidina em celulas cho tratadas pela elipticina ou vm-26
- Analise citogenetica dos efeitos da 5-azacitiduia sobre as celulas cho tratada nas fases g1, 5 e g2 do ciclo celular
- Influence of novobiocin on 'gama'-irradiated Go Lymphocytes as analized by cytogenetic endpoints
Informações sobre o DOI: 10.1016/j.ejmech.2017.08.051 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002925152.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
